Paul F. Harron Jr. Lung Center

Paul F. Harron Jr. Lung Center Faculty

faculty photo

Melpo Christofidou-Solomidou, PhD

Research Associate Professor of Medicine
Director, Pulmonary Morphology Core Laboratory, University of Pennsylvania School of Medicine, Philadelphia, PA
Investigator, Center for Excellence in Environmental Toxicology (CEET), University of Pennsylvania
Investigator, Abramson Cancer Center, University of Pennsylvania
Adjunct Faculty, Institute for Environmental Medicine (IFEM), University of Pennsylvania
Founder and Chair of the Scientific Advisory Board, LignaMed, LLC, an Upstart company in collaboration with the Penn Center for Innovation (PCI) of the University of Pennsylvania
Department: Medicine

Contact information
University of Pennsylvania, Department of Medicine
Pulmonary, Allergy and Critical Care Division
3615 Civic Center Boulevard
Abramson Research Center, Office Suite 1016C
Philadelphia, PA 19104-6160
Office: (215) 573-9917
Fax: (215) 573-4469
Education:
B.S. (Biology)
State University of New York at Stony Brook, Long Island, New York, 1983.
M.S. (Cell Biology)
Rhenish Friedrich Wilhelm’s University, Bonn, Germany, 1987.
Ph.D. (Cell Biology)
Rhenish Friedrich Wilhelm’s University, Bonn, Germany, 1991.
Post-Graduate Training
Postdoctoral Fellow, Department of Physiology & Cell Biology, Albany Medical College, Albany, NY, 1991-1992.
Postdoctoral Fellow, New York State Affiliate of the American Heart Association, Albany Medical College, Albany, NY, 1992-1993.
Postdoctoral Fellow, Department of Dermatology and Pulmonary, Allergy & Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA, 1993-1995.
Postdoctoral Fellow, Pulmonary, Allergy & Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA, 1995-1996.
Certifications
Patient Oriented Research Certification-University of Pennsylvania, 2007.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

The theme of Dr. Christofidou-Solomidou's research is pulmonary inflammation and cell adhesion molecule regulation/expression. Projects involve the development of oxidant-induced acute and chronic lung injury animal models for the study of diseases such as ARDS, sepsis, radiation induced pneumonitis/fibrosis, and oxygen toxicity. Specific projects focus on the development of antioxidant methodologies such as immune conjugates for the targeting of anti-oxidant enzymes such as Catalase and Superoxide Dismutase to the pulmonary endothelium using antibodies to endothelial antigens. Recent work extends to the use of dietary alternative antioxidant agents such as curcumin, flaxseed or phenolic compounds in ameliorating acute and chronic oxidative lung disease.

Selected Publications

Makan Khoshnejad, Vladimir V. Shuvaev, Katherine W. Pulsipher, Chuanyun Dai, Elizabeth D. Hood, Evguenia Arguiri, Melpo Christofidou-Solomidou, Ivan J. Dmochowski, Colin F. Greineder and Vladimir R. Muzykantov: Endothelial Targeting of Ferritin Nanoparticles Unveils Nano-scale Differences in Vascular Accessibility of Cell Adhesion Molecules PECAM-1 and ICAM-1. ACS Nano In Review, 2016.

Salamatipour A, Mohanty SK, Pietrofesa RA, Vann D, Christofidou-Solomidou M, and Willenbring JK: Effect of grinding conditions on toxicity and mineralogical properties of chrysotile asbestos. Toxicology In Review, 2016.

Om P. Mishra, Anatoliy V. Popov, Ralph Pietrofesa and Christofidou- Solomidou M: Secoisolariciresinol Diglucoside (SDG) Scavenges Hypochlorite Ions: A Novel Mechanism of SDG Protection of Genomic DNA from Radiation. International Journal of Radiation Oncology, Biology, Physics In Review, 2016.

Yuwaraj Kadariya, Craig W. Menges, Jacqueline Talarchek, Qi Cai, Ralph Pietrofesa, Melpo Christofidou-Solomidou, Brooke T. Mossman, Arti Shukla, and Joseph R. Testa: The NALP3 Inflammasome and IL-1 Signaling Link Asbestos-Induced Inflammation with the Development of Malignant Mesothelioma. Cancer Prevention Research In Review, 2016.

Pietrofesa RA, Velalopoulou A, Menges CW, Testa JR, Hwang WT, Albelda SM, and Christofidou-Solomidou M: Flaxseed Lignans Enriched in Secoisolariciresinol Diglucoside (SDG) Prevent Incidence of Mesothelioma in a Murine Model of Accelerated Asbestos-Induced Mesothelioma. Carcinogenesis In Prep, 2016.

Ralph A. Pietrofesa, Anastasia Velalopoulou, Evguenia Arguiri, Raymond Luke, Om P. Mishra, Wei-Ting-Whang, Steven M. Albelda and Melpo Christofidou-Solomidou: The Flaxseed Lignan Secoisolariciresinol Diglucoside (SDG) Inhibit Asbestos-Induced Inflammasome activation. Cancer Prevention Research In Review, 2016.

Vladimir V. Shuvaev, Silvia Muro, Evguenia Arguiri3 Makan Khoshnejad, Samira Tliba, Melpo Christofidou-Solomidou, and Vladimir R. Muzykantov: Size, Shape and Selection of Target Molecule Modulate Endothelial Targeting, Uptake and Anti-inflammatory Effect of Antibody-SOD Conjugate. Bioconjugate Chemistry In Press, Dec 2015.

Ming-Hui Fan, Qiang Zhu, Hui-Hua Li, Hyun-Jeong Ra, Sonali Majumdar, Daniel H. Madsen, Christofidou-Solomidou M, David W. Speicher, Sergey L. Leikin, Carol Feghali-Bostwick, Ellen Pure: Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from the Lung in Mice. Journal of Biological Chemistry In Press, Dec 2015.

Ralph A. Pietrofesa, Anastasia Velalopoulou, Evguenia Arguiri, Raymond Luke, Om P. Mishra, Wei-Ting-Whang, Steven M. Albelda and Melpo Christofidou-Solomidou: Flaxseed Lignans Enriched in Secoisolariciresinol Diglucoside (SDG) Inhibit Asbestos-Induced Peritoneal Inflammation in Mice. Carcinogenesis In Press, Dec 2015.

Anastasia Velalopoulou, Sonia Tyagi, Ralph A Pietrofesa, Evguenia Arguiri, Christofidou-Solomidou M: The Flaxseed-derived Lignan Phenolic Secoisolariciresinol Diglucoside (SDG) Protects Non-Malignant Lung Cells from Radiation Damage. International Journal of Molecular Sciences In Press, Dec 22 2015.

back to top
Last updated: 01/20/2016
The Trustees of the University of Pennsylvania